Lung Transplantation and Reverse Potts Shunt for Pulmonary Hypertension in the Pediatric Population
Pediatric Transplantation · 2026
DOI: 10.1111/petr.70263 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Timothy Klouda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Boston Children's Hospital, Hardvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Palliative Care, Clinical Decision-Making, Lung Transplantation. Die Arbeit nennt 82 Literaturangaben.
Abstract (Originalsprache)
Pulmonary hypertension (PH) is a potentially life‐threatening disorder characterized by abnormalities of the pulmonary vasculature, causing elevated pulmonary artery pressures, which can result in right ventricular dysfunction. Patients with suprasystemic right ventricular pressure unresponsive to aggressive medical therapy have limited treatment options, including balloon atrial septostomy, reverse Potts shunt, or lung transplantation. The decision to proceed to a palliative reverse Potts shunt or lung transplantation, and the choice of one or the other, depends on surgical, medical, and psychosocial factors. In this manuscript, we discuss the definition, pathophysiology, and current treatments for PH in relation to pediatric lung transplantation, including referral indications and special considerations for transplant candidates. We review the reverse Potts shunt as a palliative option for patients with severe PH, discussing indications, patient outcomes, surgical techniques, and the relative risks/benefits compared to lung transplantation. Finally, we propose an algorithm to assist pediatric cardiologists, pulmonologists, intensivists, surgeons, and other healthcare providers in the decision‐making between a palliative reverse Potts shunt procedure and lung transplantation for patients with severe PH based on currently available data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary Medicine, Boston Children's Hospital, Hardvard Medical School, Boston, Massachusetts, USA.
- Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Pulmonary and Sleep Medicine, the Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center Morgan Stanley Children's Hospital of New York Presbyterian, New York, New York, USA.
- Division of Pulmonary Medicine, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Timothy Klouda, Levent Midyat
Zitieren
APA
Klouda, T., Wong, W., Fynn-Thompson, F., Esch, J. J., Josephson, M. B., Krishnan, U. S., Midyat, L., & Mullen, M. P. (2026). Lung Transplantation and Reverse Potts Shunt for Pulmonary Hypertension in the Pediatric Population. Pediatric Transplantation. https://doi.org/10.1111/petr.70263
Vancouver
Klouda T, Wong W, Fynn-Thompson F, Esch JJ, Josephson MB, Krishnan US, et al. Lung Transplantation and Reverse Potts Shunt for Pulmonary Hypertension in the Pediatric Population. Pediatric Transplantation. 2026. doi:10.1111/petr.70263
BibTeX
@article{Klouda2026,
author = {Klouda, Timothy and Wong, Wai and Fynn-Thompson, Francis and Esch, Jesse J and Josephson, Maureen B and Krishnan, Usha S and Midyat, Levent and Mullen, Mary P},
title = {Lung Transplantation and Reverse Potts Shunt for Pulmonary Hypertension in the Pediatric Population},
journal = {Pediatric Transplantation},
year = {2026},
doi = {10.1111/petr.70263}
}
EUVIMED